938180-21-3Relevant articles and documents
Overcoming the Pregnane X Receptor Liability: Rational Design to Eliminate PXR-Mediated CYP Induction
Ramanjulu, Joshi M.,Williams, Shawn P.,Lakdawala, Ami S.,Demartino, Michael P.,Lan, Yunfeng,Marquis, Robert W.
, p. N (2021/09/02)
The pregnane X receptor (PXR) regulates expression of proteins responsible for all three phases required for the detoxification mechanism, which include CYP450 enzymes, phase II enzymes, and multidrug efflux pumps. Therefore, PXR is a prominent receptor t
Titanium(IV) isopropoxide mediated synthesis of pyrimidin-4-ones
Ramanjulu, Joshi M.,Demartino, Michael P.,Lan, Yunfeng,Marquis, Robert
scheme or table, p. 2270 - 2273 (2010/07/17)
A novel, one-step method for the synthesis of tri- and tetrasubstituted pyrimidin-4-ones is reported. This method involves a titanium(IV)-mediated cyclization involving two sequential condensations of primary and β-ketoamides. The reaction is operationally facile, readily scalable, and offers rapid entry into differentially substituted pyrimidin-4-one scaffolds. The high functional group compatibility allows for substantial diversification in the products generated from this transformation.
CALCILYTIC COMPOUNDS
-
Page/Page column 47, (2008/06/13)
Novel calcilytic compounds, pharmaceutical compositions, methods of synthesis and methods of using them are provided.